Advertisement

Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors

Abstract

Purpose

Physical activity may be difficult for survivors with poorer functioning following primary treatment. The study examined whether late symptoms of breast cancer treatment impact PA adoption (0–6 months) and maintenance (6–18 months) during a weight management intervention, and whether late symptoms influence PA when accounting for overall functioning.

Methods

Secondary analyses were conducted using a sample of survivors participating in a weight management intervention and who provided valid weight and accelerometer data at baseline and 6 months (N = 176). The Breast Cancer Prevention Trial Symptom Checklist (BCPT) assessed late treatment-related symptoms. SF-12 Physical Component Scale (PCS) and Mental Component Scale (MCS) scores assessed functioning.

Results

Change in bouted moderate to vigorous physical activity (MVPA) min/week from baseline to 6 months was not associated with BCPT scales (all p values > 0.05). When adding SF-12 scores to the model, change in bouted MVPA min/week was significantly associated with the PCS (p = 0.045). Change in MVPA min/week from 6 to 18 months was significantly associated with cognitive symptoms (p = 0.004), but not musculoskeletal or vasomotor symptoms (p values > 0.05). When adding 6-month SF-12 scores to the model, MVPA min/week was significantly associated with PCS (p = 0.001) and MCS (p = 0.028); however, BCPT cognitive problems score became non-significant (p > 0.05).

Conclusions

Poorer physical functioning was associated with lower PA adoption, and poorer mental and physical functioning was associated with lower maintenance of PA, while late symptoms generally were not. Interventionists should consider level of functioning when identifying individual PA goals during weight management interventions.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 199

This is the net price. Taxes to be calculated in checkout.

Abbreviations

PA:

Physical activity

BCPT:

Breast Cancer Prevention Trial Symptom Checklist

MVPA:

Moderate to vigorous physical activity

SF-12:

Medical Outcomes Study Short-Form 12

References

  1. 1.

    Paskett ED, Herndon JE, Day JM, Stark NN, Winer EP, Grubbs SS et al (2008) Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804. Psychooncology 17:1108–1120

  2. 2.

    Treanor C, Santin O, Mills M, Donnelly M (2013) Cancer survivors with self-reported late effects: their health status, care needs and service utilisation. Psychooncology 22:2428–2435

  3. 3.

    Cleeland CS (2007) Symptom burden: multiple symptoms and their impact as patient-reported outcomes. JNCI Monogr 37:16–21

  4. 4.

    Groenvold M, Fayers PM, Petersen MA, Sprangers MAG, Aaronson NK, Mouridsen HT (2007) Breast cancer patients on adjuvant chemotherapy report a wide range of problems not identified by health-care staff. Breast Cancer Res Treat 103:185–195

  5. 5.

    Khan QJ, O’Dea AP, Sharma P (2010) Musculoskeletal adverse events associated with adjuvant aromatase inhibitors. J Oncol. https://doi.org/10.1155/2010/654348

  6. 6.

    Laroche F, Coste J, Medkour T, Cottu PH, Pierga J-Y, Lotz J-P et al (2014) Classification of and risk factors for estrogen deprivation pain syndromes related to aromatase inhibitor treatments in women with breast cancer: a prospective multicenter cohort study. J Pain 15:293–303

  7. 7.

    Menas P, Merkel D, Hui W, Lawton J, Harper A, Carro G (2012) Incidence and management of arthralgias in breast cancer patients treated with aromatase inhibitors in an outpatient oncology clinic. J Oncol Pharm Pract 8:387–393

  8. 8.

    Carpenter JS, Johnson D, Wagner L, Andrykowski M (2002) Hot flashes and related outcomes in breast cancer survivors and matched comparison women. Oncol Nurs Forum 29:E16–E25

  9. 9.

    Chandwani KD, Heckler CE, Mohile SG, Mustian KM, Janelsins M, Peppone LJ et al (2014) Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer. Explore (NY) 10:241–247

  10. 10.

    Chang H-Y, Jotwani AC, Lai Y-H, Jensen MP, Syrjala KL, Fann JR et al (2016) Hot flashes in breast cancer survivors: frequency, severity and impact. The Breast 27:116–121

  11. 11.

    Marino JL, Saunders CM, Emery LI, Green H, Doherty DA, Hickey M (2014) Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history. Menopause 21:267–274

  12. 12.

    Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD et al (2016) Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. https://doi.org/10.1002/cncr.30208

  13. 13.

    Wefel JS, Saleeba AK, Buzdar AU, Meyers CA (2010) Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer 116:3348–3356

  14. 14.

    Terhorst L, Blair-Belansky H, Moore PJ, Bender C (2011) Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy. Psychooncology 20:961–968

  15. 15.

    Cella D, Land SR, Chang C-H, Day R, Costantino JP, Wolmark N et al (2008) Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Res Treat 109:515–526

  16. 16.

    Alfano CM, McGregor BA, Kuniyuki A, Reeve BB, Bowen DJ, Baumgartner KB et al (2006) Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors. Psychooncology 15:985–1000

  17. 17.

    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, nutrition, physical activity and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC

  18. 18.

    Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH (2010) An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 4:87–100

  19. 19.

    Friedenreich CM, Neilson HK, Farris MS, Courneya KS (2016) Physical activity and cancer outcomes: a precision medicine approach. Clin Cancer Res Off J Am Assoc Cancer Res 22:4766–4775

  20. 20.

    Hefferon K, Murphy H, McLeod J, Mutrie N, Campbell A (2013) Understanding barriers to exercise implementation 5-year post-breast cancer diagnosis: a large-scale qualitative study. Health Educ Res 28:843–856

  21. 21.

    Emery CF, Yang H-C, Frierson GM, Peterson LJ, Suh S (2009) Determinants of physical activity among women treated for breast cancer in a 5-year longitudinal follow-up investigation. Psychooncology 18:377–386

  22. 22.

    Brown JC, Mao JJ, Stricker C, Hwang W-T, Tan K-S, Schmitz KH (2014) Aromatase inhibitor associated musculoskeletal symptoms are associated with reduced physical activity among breast cancer survivors. Breast J 20:22–28

  23. 23.

    Lee CE, Von Ah D, Szuck B, Lau Y-KJ (2016) Determinants of physical activity maintenance in breast cancer survivors after a community-based intervention. Oncol Nurs Forum 43:93–102

  24. 24.

    Befort CA, Klemp JR, Sullivan DK, Shireman T, Diaz FJ, Schmitz K et al (2016) Weight loss maintenance strategies among rural breast cancer survivors: the rural women connecting for better health trial. Obesity 24:2070–2077

  25. 25.

    Befort CA, Bennett L, Christifano D, Klemp JR, Krebill H (2014) Effective recruitment of rural breast cancer survivors into a lifestyle intervention. Psychooncology 24:487–490

  26. 26.

    Brage S, Wedderkopp N, Franks PW, Andersen LB, Froberg K (2003) Reexamination of validity and reliability of the CSA monitor in walking and running. Med Sci Sports Exerc 35:1447–1454

  27. 27.

    Bassett DR, Ainsworth BE, Swartz AM, Strath SJ, O’Brien WL, King GA (2000) Validity of four motion sensors in measuring moderate intensity physical activity. Med Sci Sports Exerc 32(9):S471–S480

  28. 28.

    Mâsse LC, Fuemmeler BF, Anderson CB, Matthews CE, Trost SG, Catellier DJ et al (2005) Accelerometer data reduction: a comparison of four reduction algorithms on select outcome variables. Med Sci Sports Exerc 37(11):S544–S554

  29. 29.

    Jakicic JM, Tate DF, Lang W, Davis KK, Polzien K, Neiberg RH et al (2014) Objective physical activity and weight loss in adults: the step-up randomized clinical trial. Obes Silver Spring Md 22:2284–2292

  30. 30.

    Matthews CE, Ainsworth BE, Thompson RW, Bassett DR (2002) Sources of variance in daily physical activity levels as measured by an accelerometer. Med Sci Sports Exerc 34:1376–1381

  31. 31.

    Stanton AL, Bernaards CA, Ganz PA (2005) The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. J Natl Cancer Inst 97:448–456

  32. 32.

    Ware J, Kosinski M, Keller SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233

  33. 33.

    Treanor C, Donnelly M (2015) A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors. Qual Life Res 24:339–362

  34. 34.

    United States Department of Agriculture. (2010) USDA Economic Research Service—Rural-Urban Commuting Area Codes. http://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx. Accessed 4 Dec 2015

  35. 35.

    Goodwin PJ, Segal RJ, Vallis M, Ligibel JA, Pond GR, Robidoux A et al (2014) Randomized trail of a telephone-based weight loss intervention in postmenopausal women with breast cancer receiving letrozole: the LISA trail. J Clin Oncol 32:2231–2239

Download references

Author information

Correspondence to Christie Befort.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

All procedures performed in the study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The research was approved by the University’s Institution Review Board and informed consent was obtained from all participants. The study is compliant with U.S. laws for research and ethics.

Additional information

Data availability

The dataset for the current study is available from the corresponding author on reasonable request.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fazzino, T.L., Klemp, J. & Befort, C. Late breast cancer treatment-related symptoms and functioning: associations with physical activity adoption and maintenance during a lifestyle intervention for rural survivors. Breast Cancer Res Treat 168, 755–761 (2018) doi:10.1007/s10549-017-4603-z

Download citation

Keywords

  • Late treatment-related symptoms
  • Physical activity
  • Breast Cancer Prevention Trial Symptom Checklist
  • Breast cancer survivors